These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32077352)

  • 1. Spontaneous remission and clonal evolution in lenalidomide associated secondary AML.
    Waller DD; Monczak Y; Michel RP; Shustik C; Sebag M
    Leuk Lymphoma; 2020 Jul; 61(7):1724-1727. PubMed ID: 32077352
    [No Abstract]   [Full Text] [Related]  

  • 2. Single-cell mutational profiling enhances the clinical evaluation of AML MRD.
    Ediriwickrema A; Aleshin A; Reiter JG; Corces MR; Köhnke T; Stafford M; Liedtke M; Medeiros BC; Majeti R
    Blood Adv; 2020 Mar; 4(5):943-952. PubMed ID: 32150611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lenalidomide results in a durable complete remission in acute myeloid leukemia accompanied by persistence of somatic mutations and a T-cell infiltrate in the bone marrow.
    Bansal D; Vij K; Chang GS; Miller CA; DiPersio JF; Vij R; Heath SE; Westervelt P; Welch JS; Fehniger TA
    Haematologica; 2018 Jun; 103(6):e270-e273. PubMed ID: 29567774
    [No Abstract]   [Full Text] [Related]  

  • 4. Clonal evolution of acute myeloid leukemia from diagnosis to relapse.
    Vosberg S; Greif PA
    Genes Chromosomes Cancer; 2019 Dec; 58(12):839-849. PubMed ID: 31478278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous remission of acute myeloid leukemia after discontinuation of lenalidomide.
    Kremer B; Tsai DE; Debonera F; Cohen PL; Schuster SJ
    Leuk Lymphoma; 2018 Mar; 59(3):743-745. PubMed ID: 28695787
    [No Abstract]   [Full Text] [Related]  

  • 6. Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia.
    Rothenberg-Thurley M; Amler S; Goerlich D; Köhnke T; Konstandin NP; Schneider S; Sauerland MC; Herold T; Hubmann M; Ksienzyk B; Zellmeier E; Bohlander SK; Subklewe M; Faldum A; Hiddemann W; Braess J; Spiekermann K; Metzeler KH
    Leukemia; 2018 Jul; 32(7):1598-1608. PubMed ID: 29472724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AML evolution from preleukemia to leukemia and relapse.
    Shlush LI; Mitchell A
    Best Pract Res Clin Haematol; 2015; 28(2-3):81-9. PubMed ID: 26590763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal evolution and devolution after chemotherapy in adult acute myelogenous leukemia.
    Parkin B; Ouillette P; Li Y; Keller J; Lam C; Roulston D; Li C; Shedden K; Malek SN
    Blood; 2013 Jan; 121(2):369-77. PubMed ID: 23175688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic changes in the clonal structure of MDS and AML in response to epigenetic therapy.
    Uy GL; Duncavage EJ; Chang GS; Jacoby MA; Miller CA; Shao J; Heath S; Elliott K; Reineck T; Fulton RS; Fronick CC; O'Laughlin M; Ganel L; Abboud CN; Cashen AF; DiPersio JF; Wilson RK; Link DC; Welch JS; Ley TJ; Graubert TA; Westervelt P; Walter MJ
    Leukemia; 2017 Apr; 31(4):872-881. PubMed ID: 27740633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The priming induction regimen of HAG as a low dose chemotherapy strategy in AML clonal evolution.
    Chen A; Yang J; Hu S; Wang QF
    Sci China Life Sci; 2015 Dec; 58(12):1302-5. PubMed ID: 26588914
    [No Abstract]   [Full Text] [Related]  

  • 11. Single-agent lenalidomide induces complete remission of acute myeloid leukemia in patients with isolated trisomy 13.
    Fehniger TA; Byrd JC; Marcucci G; Abboud CN; Kefauver C; Payton JE; Vij R; Blum W
    Blood; 2009 Jan; 113(5):1002-5. PubMed ID: 18824593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clonal selection in therapy-related myelodysplastic syndromes and acute myeloid leukemia under azacitidine treatment.
    Calleja A; Yun S; Moreilhon C; Karsenti JM; Gastaud L; Mannone L; Komrokji R; Al Ali N; Dadone-Montaudie B; Robert G; Auberger P; Raynaud S; Sallman DA; Cluzeau T
    Eur J Haematol; 2020 May; 104(5):488-498. PubMed ID: 31990086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal genetic evolution at relapse of favorable-risk acute myeloid leukemia with
    Martínez-Losada C; Serrano-López J; Serrano-López J; Noguera NI; Garza E; Piredda L; Lavorgna S; Consalvo MAI; Ottone T; Alfonso V; Peinado JR; Garcia-Ortiz MV; Morales-Ruiz T; Jérez A; Hurtado AM; Montesinos P; Cervera J; Such E; Ibañez M; Sempere A; Sanz MÁ; Lo-Coco F; Sánchez-García J
    Haematologica; 2018 Sep; 103(9):e400-e403. PubMed ID: 29622659
    [No Abstract]   [Full Text] [Related]  

  • 14. Minimal/Measurable Residual Disease Monitoring in
    Forghieri F; Comoli P; Marasca R; Potenza L; Luppi M
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30404199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinguishing clonal evolution from so-called secondary acute myelogenous leukemia: Adhering to unifying concepts of the genetic basis of leukemogenesis.
    Lichtman MA
    Blood Cells Mol Dis; 2015 Jun; 55(1):1-2. PubMed ID: 25976458
    [No Abstract]   [Full Text] [Related]  

  • 16. Clonal evolution of Philadelphia chromosome in acute myeloid leukemia after enasidenib treatment.
    Ramkissoon LA; Buhlinger K; Nichols A; Coombs CC; Foster MC; Galeotti J; Kaiser-Rogers K; Richardson DR; Montgomery ND; Zeidner JF
    Leuk Lymphoma; 2021 Dec; 62(12):3035-3038. PubMed ID: 34151687
    [No Abstract]   [Full Text] [Related]  

  • 17. Clonal evolution of acute myeloid leukemia relapsed after 19 years of remission.
    Takahashi K; Roh W; Zhang J; Propotopov A; Patel K; Strickland S; Kim A; Vnencak-Jones C; Pelletier S; Parmar S; Garcia-Manero G; Kornblau S; Chin L; Kantarjian H; Futreal PA; Ravandi F
    Am J Hematol; 2015 Jul; 90(7):E134-5. PubMed ID: 25801490
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acute myeloid leukemia: molecular pathogenesis and new therapeutic strategies].
    Goyama S
    Rinsho Ketsueki; 2016 Feb; 57(2):118-28. PubMed ID: 26935629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing.
    Masetti R; Castelli I; Astolfi A; Bertuccio SN; Indio V; Togni M; Belotti T; Serravalle S; Tarantino G; Zecca M; Pigazzi M; Basso G; Pession A; Locatelli F
    Oncotarget; 2016 Aug; 7(35):56746-56757. PubMed ID: 27462774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-exome sequencing reveals the spectrum of gene mutations and the clonal evolution patterns in paediatric acute myeloid leukaemia.
    Shiba N; Yoshida K; Shiraishi Y; Okuno Y; Yamato G; Hara Y; Nagata Y; Chiba K; Tanaka H; Terui K; Kato M; Park MJ; Ohki K; Shimada A; Takita J; Tomizawa D; Kudo K; Arakawa H; Adachi S; Taga T; Tawa A; Ito E; Horibe K; Sanada M; Miyano S; Ogawa S; Hayashi Y
    Br J Haematol; 2016 Nov; 175(3):476-489. PubMed ID: 27470916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.